Round Lake Park, IL, United States of America

Keith Brian Ryther

This inventor holds 15 USPTO granted patents, primarily in CNS Drug Development. Top assignees: Abbott Laboratories Corporation, Abbvie Inc.. Active years: 1997-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Keith Brian Ryther. Retrieved from https://idiyas.com/inventor/keith-brian-ryther

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 66.7

Average Co-Inventor Count = 7.5

ph-index = 7

Forward Citations = 186(Granted Patents)


Location History:

  • Round Lake Park, IL (US) (1997 - 2013)
  • Evansville, IN (US) (2014 - 2015)

Company Filing History:


Years Active: 1997-2015

Loading Chart...
Areas of Expertise:
Cannabinoid Receptor
CNS Agents
Analgesics
Heterocyclic Compounds
Aminoazacycles
Chemical Transmission
Pyridyl Enantiomers
Furopyridine
Thienopyridine
Pyrrolopyridine
Hexahydro
Ether Compounds
15 patents (USPTO):Explore Patents

Title: Keith Brian Ryther: Innovator in Cannabinoid Research

Introduction

Keith Brian Ryther is a notable inventor based in Round Lake Park, Illinois, with a significant contribution to the field of cannabinoid research. He holds a total of 15 patents, showcasing his innovative approach to developing compounds that interact with cannabinoid receptors. His work has implications for treating various medical conditions and disorders.

Latest Patents

Among his latest patents, Ryther has developed compounds that serve as cannabinoid receptor ligands. These inventions include formulations that consist of specific compounds, their pharmaceutical salts, prodrugs, and combinations thereof. The patents detail methods for treating conditions and disorders using these compounds and compositions, highlighting their potential therapeutic applications.

Career Highlights

Throughout his career, Ryther has worked with prominent companies in the pharmaceutical industry, including Abbott Laboratories Corporation and AbbVie Inc. His experience in these organizations has contributed to his expertise in cannabinoid research and development.

Collaborations

Ryther has collaborated with notable colleagues such as Nan-Horng Lin and Mark W Holladay, further enhancing the scope and impact of his research in cannabinoid receptor ligands.

Conclusion

Keith Brian Ryther's contributions to cannabinoid research through his patents and collaborations reflect his dedication to advancing medical science. His innovative work continues to pave the way for new treatments and therapies in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…